GLPcompareGLPcompare
DrugsPricesProvidersCompareShortagesEvidenceSupplementsWatchlist
HomePricesFoundayo
US self-pay prices

Foundayo price without insurance

Foundayo contains orforglipron and is made by Eli Lilly. Its lowest current self-pay price is $149/mo, across 1 sourced offer. Prices below are by form and dose, each with its seller, conditions and check date.

Foundayo tablet

Once daily, with or without food

Advertised entry price

from $149/mo

30-day supply

$149 per 30 days at this quoted rate

Checked Sep 30, 2026

Foundayo (LillyDirect self-pay)

LillyDirect (Eli Lilly) · Manufacturer direct

self-pay cash, lowest dose; ~$25/mo with commercial coverage

Price conditions

self-pay cash, lowest dose; ~$25/mo with commercial coverage

The first oral small-molecule GLP-1 pill for weight loss; FDA-approved April 2026. LillyDirect self-pay ladder: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.

30-day supply

Published maintenance dose

$299/mo

30-day supply

$299 per 30 days at this quoted rate

Checked Sep 30, 2026

At 17.2 mg

Foundayo (LillyDirect self-pay)

LillyDirect (Eli Lilly) · Manufacturer direct

Published price at 17.2 mg

Price conditions

Published price at 17.2 mg

The first oral small-molecule GLP-1 pill for weight loss; FDA-approved April 2026. LillyDirect self-pay ladder: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.

Self-Pay Journey price for 14.5 mg and 17.2 mg with a refill within 45 days; regular price $349. Eligibility, additional taxes and fees may apply.

30-day supply

Every cash quote was checked on or after Sep 26, 2026. Each quote shows its own check date. A quoted dose is not a dosing recommendation. How we source prices

Every sourced offer

All Foundayo offers

Manufacturer, pharmacy and telehealth quotes for Foundayo itself. Compounded orforglipron is a different, unapproved product and is listed on the main price page.

Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.

Compare every GLP-1 price
Trial results

What Foundayo showed in trials

Each result belongs to its named trial and dose. Trial averages do not predict an individual's result.

Foundayo tablet

−11.2% (-11.2% at 72 wks · ATTAIN-1 · 17.2 mg daily (Foundayo; 36 mg capsule-equivalent in ATTAIN-1))

ATTAIN-1 · -11.2% at 72 wks

17.2 mg daily (Foundayo; 36 mg capsule-equivalent in ATTAIN-1)

Accounts for treatment discontinuation

US prescribing information

Approved uses

Eligibility, contraindications and warnings are in the full prescribing information.

Foundayo tablet

Weight management in adults with obesity, or overweight with a weight-related condition.

US prescribing information (Foundayo Tablet prescribing information)

Reviewed Sep 22, 2026

FDA shortage status

Is Foundayo in shortage?

No shortage reported

No matching shortage record was returned in the latest complete FDA check. This status covers orforglipron as a whole; last complete check Oct 9, 2026. National reporting does not confirm stock at your pharmacy.

All GLP-1 shortage reports
Questions

Foundayo cost: common questions

How much does Foundayo cost without insurance?

From $149/mo at LillyDirect (Eli Lilly) ($149 per 30 days at this quoted rate); $299/mo at 17.2 mg. These are self-pay prices from the sellers' own pages, not insurance estimates; the conditions and refill rules listed with each quote apply.

What is Foundayo approved for?

Weight management in adults with obesity, or overweight with a weight-related condition.

Is Foundayo in shortage?

No matching shortage record was returned in the latest complete FDA check. This status covers orforglipron as a whole; last complete check Oct 9, 2026. Confirm local stock with your pharmacy.

Orforglipron: evidence and safety
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.
GLPcompareGLPcompare

The live, fully-cited reference for the GLP-1 ecosystem. Every figure traces to its source. Informational only, not medical advice.

Product

  • Drugs
  • Prices
  • Providers
  • Compare
  • Shortages
  • Evidence
  • Supplements

Legal

  • Methodology
  • About
  • News
  • Price updates
  • Privacy Policy
  • Terms of Service
  • Support

Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.

© 2026 GLPcompare. All rights reserved.

Fazier #5 Product of the DayGLPcompare on LaunchNestFeatured on SaaSCityFeatured on LaunchBuffLeave a review for GLPcompare on Indie Need
How much weight loss did Foundayo show in trials?

In ATTAIN-1, 17.2 mg daily (Foundayo; 36 mg capsule-equivalent in ATTAIN-1) showed a mean body-weight change of -11.2% at 72 wks. This is a trial average; individual results vary.

Search by medication, provider or treatment goal. Examples follow.

1 offers · US self-pay · 1 maintenance quotes

ProductProviderAdvertised priceMaintenance priceDetails
  • Foundayo (LillyDirect self-pay)

    Orforglipron · Manufacturer direct

    L
    LillyDirect (Eli Lilly)
    Advertised pricefrom $149/mo

    30-day supply

    $149 per 30 days at this quoted rate

    Checked Sep 30, 2026

    self-pay cash, lowest dose; ~$25/mo with commercial coverage

    Maintenance price$299/mo

    At 17.2 mg

    30-day supply

    $299 per 30 days at this quoted rate

    Checked Sep 30, 2026

    View offer

    Maintenance terms: Self-Pay Journey price for 14.5 mg and 17.2 mg with a refill within 45 days; regular price $349. Eligibility, additional taxes and fees may apply.

    Price conditions & sourceChecked Sep 30, 2026

    The first oral small-molecule GLP-1 pill for weight loss; FDA-approved April 2026. LillyDirect self-pay ladder: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Ingredient-level FDA shortage report:No shortage reportedOpen record
    Read the advertised-price source

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.